Following the ARSEP publication, I wrote an e-mail to a scientist who works for ARSEP.
I asked what was the Arsep plannig to do (specific studies, further research, clinical trials...)
The answer was in brief, that everything as to be controlled, with a call for proposals, a talk with three world experts, an argumented debate, a decision from the ARSEP scientific comity.
Eventhough we feel better since this article has been published, we find Arsep isn't as excited as we (patients) are.
Dr Lubetsky (Pitié-Salpêtrière-Paris) leads the ARSEP scientific board. Her position is quite critical regardingCCSVI.
French patients are active and excited, we have a big hope that MS research is at a turning point.